Roughly half a year after introducing the new regulatory pathway, the FDA has greenlit the first drug under its ultra-speedy—and controversial—Commissioner’s National Priority Voucher pilot review program. The inaugural approval under the program has gone to USAntibiotics and its domestically manufactured extended-release antibiotic Augmentin XR.
FDA awards 1st national priority nod to USAntibiotics’ Augmentin XR
Latest from Blog
NEWS CENTER Maine
Through in-depth storytelling, through direct contact on digital on social platforms, through long-standing community service programs like Coats & Toys for Kids, Project Heat and Buddy to Buddy, NEWS CENTER Maine is
Four Rules for Fueling that Every Senior Cyclist Should Follow, According to a Dietitian and Cycling Coach
Thankfully, the era of “eating is cheating” is over. Post Views: 4
It’s Nutrition and Hydration Week — Here’s some tips on how to eat healthy on a budget
This week is Nutrition and Hydration Week, an annual week aimed at highlighting and promoting improvements in nutrition and hydration. Local organizations like Second Harvest Food Bank said eating wel… Post Views:
STAT+: Automatic enrollment in Medicare Advantage plans under consideration, top Trump health official says
President Trump’s Medicare director said Thursday his team is considering a policy that would automatically enroll Medicare beneficiaries into Medicare Advantage plans, a controversial idea that was touted in the conservative Project